IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 278 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $115,656 | -3.3% | 18,929 | +1.1% | 0.01% | -12.5% |
| Q4 2022 | $119,627 | -30.0% | 18,721 | +4.9% | 0.01% | -27.3% |
| Q3 2022 | $171,000 | -36.7% | 17,842 | +10.2% | 0.01% | -21.4% |
| Q1 2022 | $270,000 | +8.0% | 16,190 | +23.6% | 0.01% | -6.7% |
| Q4 2021 | $250,000 | -64.7% | 13,101 | -14.2% | 0.02% | -70.6% |
| Q4 2020 | $708,000 | +17.0% | 15,264 | -16.9% | 0.05% | +155.0% |
| Q3 2020 | $605,000 | – | 18,365 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 11,826,299 | $130,562,000 | 4.09% |
| MPM BioImpact LLC | 1,200,000 | $13,248,000 | 3.68% |
| Finepoint Capital LP | 960,200 | $10,601,000 | 3.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,011 | $273,000,000 | 2.85% |
| Avoro Capital Advisors LLC | 9,220,000 | $101,789,000 | 2.01% |
| Long Focus Capital Management, LLC | 1,625,000 | $17,940,000 | 1.88% |
| 683 Capital Management, LLC | 2,000,000 | $22,080,000 | 1.56% |
| Parametrica Management Ltd | 115,870 | $1,268,000 | 1.38% |
| Boxer Capital, LLC | 1,935,133 | $21,364,000 | 1.35% |
| Soleus Capital Management, L.P. | 719,600 | $7,944,000 | 1.24% |